Abstract Engineered metal-oxide nanoparticles have greatly been used in various bio-applications, but their physicochemical properties change dramatically within a bio-system. Therefore, the development of new metal-oxide nanoparticles and proper understanding… Click to show full abstract
Abstract Engineered metal-oxide nanoparticles have greatly been used in various bio-applications, but their physicochemical properties change dramatically within a bio-system. Therefore, the development of new metal-oxide nanoparticles and proper understanding of their toxicity profile in bio-environment are very important for advancement of cancer-related diagnostic and therapeutic approaches. Nanostructured wide-bandgap semiconductors ZnSn(OH)6 and Zn2SnO4 are fabricated by one-pot hydrothermal synthesis and tested for the first time in anti-cancer treatments. The crystalline zinc-hydroxystannate is converted by high-temperature annealing into amorphous and then crystalline zinc-orthostannate, as confirmed by Rietveld refinement analyses. A dose-dependent cytotoxicity is observed when human cervical carcinoma cell lines are exposed to these nanomaterials, mainly due to the elevation of intracellular reactive-oxygen-species levels in the treated cells, which leads to oxidative stress and cell damage. The crystalline phases of the nanomaterials reveal better cell-killing efficacy due to the overlap of the conduction-band energy levels with the cellular redox potential, leading to favorable electron transfer from the biological redox couples to the conduction-band of the semiconductor nanoparticles, thus producing more reactive-oxygen-species for cell damage. Importantly, this higher reactive-oxygen-species production by the crystalline samples significantly reduces cancer cell migration and proliferation and decreases metastasis, which remains an unmet challenge in cancer therapy.
               
Click one of the above tabs to view related content.